“Someone’s sitting in the shade today because someone planted a tree a long time ago.”
— Warren Buffett
A long-term investment in CVS Health Corporation can be evaluated most clearly through total return: share price appreciation plus dividends reinvested over time. Using that framework, a $10,000 investment in NYSE: CVS made on 08/10/2006 would have grown to $43,373.77 by 08/07/2026, assuming dividends were reinvested throughout the holding period.
That result translates to a cumulative total return of 334.13% and an average annual return of 7.61%. The exercise illustrates a central feature of buy-and-hold investing: even when the ending share price gain alone does not tell the full story, disciplined reinvestment can materially increase ending wealth over multi-decade periods.
CVS 20-Year Return Details
| Start date: | 08/10/2006 |
|
|||
| End date: | 08/07/2026 | ||||
| Start price/share: | $33.80 | ||||
| End price/share: | $95.70 | ||||
| Starting shares: | 295.86 | ||||
| Ending shares: | 453.64 | ||||
| Dividends reinvested/share: | $29.31 | ||||
| Total return: | 334.13% | ||||
| Average annual return: | 7.61% | ||||
| Starting investment: | $10,000.00 | ||||
| Ending investment: | $43,373.77 | ||||
The above figures indicate that the investment outcome was driven by both capital appreciation and compounding from reinvested distributions. An investor starting with 295.86 shares would have ended with 453.64 shares, meaning a meaningful portion of the final value came from owning more shares over time, not just from a higher stock price.
[These numbers were computed with the Dividend Channel DRIP Returns Calculator.]
What Drove the Return
CVS Health’s long-run return profile reflects the economics of a mature healthcare and pharmacy business rather than a purely high-growth equity story. Over time, shareholders benefited from three distinct levers:
- Share price appreciation: the stock rose from $33.80 to $95.70 over the measurement period.
- Cash dividends: CVS paid $29.31 per share in cumulative dividends over the period used in this analysis.
- Dividend reinvestment: reinvesting those dividends increased the share count from 295.86 to 453.64 shares.
That distinction matters. Price return alone can understate the value created by a dividend-paying stock over long holding periods. Reinvestment adds an incremental compounding layer, especially when distributions continue through different market cycles.
Dividend Yield and Yield on Cost
Based on the most recent annualized dividend rate of $2.66 per share, CVS has a current yield of approximately 2.78%. A related measure is yield on cost, which compares today’s annual dividend with the original purchase price. Using the 2006 entry price of $33.80 per share, the current dividend implies a yield on cost of 8.22%.
Yield on cost is useful for illustrating how dividend growth can improve income generation for long-term holders. It is less useful, however, for comparing fresh investment opportunities, since new buyers must evaluate the stock using the current market price, current yield, payout sustainability, balance sheet strength, and operating outlook.
Why CVS Is an Interesting Long-Term Case Study
CVS is not simply a retail pharmacy operator. Over the years, the company has evolved into a broader healthcare platform spanning pharmacy services, retail pharmacy, and health benefits. That business mix has implications for valuation and risk: reimbursement pressure, healthcare policy changes, utilization trends, integration execution, and debt management can all influence long-term shareholder returns.
For that reason, a 20-year return analysis is most useful when read as a study in compounding rather than as proof of a linear investment outcome. Even strong long-term results can include extended stretches of volatility, multiple valuation regimes, and changing market expectations about earnings quality and capital allocation.
Key Takeaways
- A $10,000 investment in CVS Health in August 2006 grew to $43,373.77 by August 2026 with dividends reinvested.
- The total return was 334.13%, equal to an average annual return of 7.61%.
- Dividend reinvestment materially increased the ending share count and final portfolio value.
- The stock’s income profile improved over time for the original buyer, with yield on cost reaching 8.22% based on the current annualized dividend.
Long holding periods can make the mechanics of total return easier to see. In CVS Health’s case, the outcome was not driven by share price alone. The combination of dividends, reinvestment, and time turned a modest initial position into a meaningfully larger asset base over two decades.
One more investment quote to leave you with:
“To achieve satisfactory investment results is easier than most people realize; to achieve superior results is harder than it looks.” — Benjamin Graham
